Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

Bionor acquires HIV vaccine candidate Vacc-CRX from Immunor

Jan. 15, 2019

IAVI initiates phase I trial of BG505 SOSIP.664 gp140 in HIV-uninfected subjects

Jan. 9, 2019

Innate immunity shuttles antigens to B-cell centers

Dec. 31, 2018

Metabolic strategy could tackle HIV reservoir, other infections

Dec. 21, 2018

EC grants approval to Delstrigo and Pifeltro for HIV-1 infection

Nov. 29, 2018

ViiV Healthcare presents HIV replication inhibitors

Nov. 28, 2018

Juluca approved in Japan

Nov. 26, 2018

NIH grant supports IBBR's development of antibody therapeutic against HIV-1

Nov. 20, 2018

Sleeper HIV can be napping or conked out

Nov. 20, 2018

Novel rBCG:HIV vaccine candidates with a ChAd.HIV boost show safety and immunogenicity in vivo

Nov. 13, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...